KATELYN KOZINSKI-BURKHART: Open Payments
NPI 1962106955 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 32 payments from 12 companies in 2025. Trend: 2023 $721 · 2024 $958 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 6 | $140 |
| Amgen Inc. | 6 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Exact Sciences Corporation | 2 | $57 |
| PFIZER INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Boston Scientific Corporation | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
Products named: REXULTI, OTEZLA, XIFAXAN, REPATHA, AIRSUPRA, TRELEGY ELLIPTA, Cologuard Collection Kit, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
